In summary, COVID-19 upregulates both IRAK2 and CHUK, while atherosclerosis only upregulates CHUK, and cardiomyopathy upregulates IRAK2, suggesting that NF-kB activation may be critical in all three conditions. The gene discussed is CHUK; the disease is COVID-19.